Historical record - last NADAC effective date: 6/21/2017
This NDC is on FDA's drug shortage list (posted Dec 20, 2023)
Reported reason: Other
Product Information
FENTANYL 100 MCG/2 ML AMPUL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.5981 per ML under NDC 00641602410. Its NADAC has been published 169 times since Nov 19, 2014.
FDA first approved this application on Jul 11, 1984. Its Orange Book therapeutic-equivalence code is AP.
The Low Outlier badge above means this manufacturer's average price in the Fentanyl Citrate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 ug/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00641602410
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
6/21/2017
Active Ingredients
FENTANYL CITRATEApproval Type
New Drug (NDA)
FDA Application
NDA019101FDA Approved
7/11/1984
TE Code
AP
On Market Since
7/11/1984
Pharmacological Classes
Price Statistics
The NADAC for FENTANYL 100 MCG/2 ML AMPUL has been published 169 times since Nov 19, 2014, and over the history we have for it it has declined 7.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5981 per ML |
|---|---|
| All-time high | $0.6450 (Jan 14, 2015) |
| All-time low | $0.5981 (Jun 21, 2017) |
| Median price | $0.6120 |
| Average price | $0.6097 |
| Largest weekly change | -5.0% (Jan 21, 2015) |
| Weeks tracked | 169 |
| Tracking since | Nov 19, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-7.3%
Last surveyed Jun 13, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FENTANYL 100 MCG/2 ML AMPUL?
The current National Average Drug Acquisition Cost (NADAC) for FENTANYL 100 MCG/2 ML AMPUL, manufactured by Hikma Pharmaceuticals USA Inc., is $0.5981 per ML (NDC 00641602410), effective Jun 13, 2018.
How has the price of FENTANYL 100 MCG/2 ML AMPUL changed over time?
Over the history we have for it, the NADAC for FENTANYL 100 MCG/2 ML AMPUL has declined 7.3%. It has been tracked across 169 weekly CMS publications since Nov 19, 2014.
What are the highest and lowest recorded NADAC prices for FENTANYL 100 MCG/2 ML AMPUL?
Since Nov 19, 2014, the NADAC for FENTANYL 100 MCG/2 ML AMPUL has ranged from a low of $0.5981 (Jun 21, 2017) to a high of $0.6450 (Jan 14, 2015), with a median of $0.6120 per ML.
Are there cheaper alternatives to FENTANYL 100 MCG/2 ML AMPUL?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FENTANYL 100 MCG/2 ML AMPUL in a comparable dosage form, but none are currently priced below it.
Who manufactures FENTANYL 100 MCG/2 ML AMPUL?
FENTANYL 100 MCG/2 ML AMPUL (NDC 00641602410) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Is FENTANYL 100 MCG/2 ML AMPUL in shortage?
Yes — NDC 00641602410 is currently listed in FDA's drug shortage database (posted Dec 20, 2023). Reported reason: Other.